Guaraná (Paullinia cupana) for chemotherapy-related fatigue

Objective: To evaluate the effect of guarana in patients with solid tumors starting on chemotherapy, insofar as chemotherapy-induced fatigue and depressive symptoms are concerned. Methods: This is a double-blind, cross-over trial in which chemotherapy naive patients were randomized to take either gu...

Full description

Bibliographic Details
Main Authors: Auro Del Giglio, Rachel Riechelmann, Thaís Zampa de Campos Trindade, Vinicius de Oliveira, Lucas Scatigno Saad, Flávia Delgado Martins, Ângelo Bezerra de Souza Fêde, Damila Cristina Trufelli, Vanessa da Costa Miranda
Format: Article
Language:English
Published: Instituto Israelita de Ensino e Pesquisa Albert Einstein 2008-09-01
Series:Einstein (São Paulo)
Subjects:
Online Access:http://www.einstein.br/revista/arquivos/PDF/846-Einsteinv6n2p195-9.pdf
_version_ 1818661683034324992
author Auro Del Giglio
Rachel Riechelmann
Thaís Zampa de Campos Trindade
Vinicius de Oliveira
Lucas Scatigno Saad
Flávia Delgado Martins
Ângelo Bezerra de Souza Fêde
Damila Cristina Trufelli
Vanessa da Costa Miranda
author_facet Auro Del Giglio
Rachel Riechelmann
Thaís Zampa de Campos Trindade
Vinicius de Oliveira
Lucas Scatigno Saad
Flávia Delgado Martins
Ângelo Bezerra de Souza Fêde
Damila Cristina Trufelli
Vanessa da Costa Miranda
author_sort Auro Del Giglio
collection DOAJ
description Objective: To evaluate the effect of guarana in patients with solid tumors starting on chemotherapy, insofar as chemotherapy-induced fatigue and depressive symptoms are concerned. Methods: This is a double-blind, cross-over trial in which chemotherapy naive patients were randomized to take either guarana 75 mg or placebo tablets during the first cycle of chemotherapy and then switched to the alternative for the second cycle. We evaluated fatigue and depressive symptoms using Portuguese-validated instruments: Chalder Fatigue Scale, Brief Fatigue Inventory, and Beck Depression Inventory. Rresults: From January to June 2007, 38 patients were recruited and 12 dropped out before outcome assessments. We did not observe any statistically significant differences between or within groups in fatigue or depression scores among the 26 evaluable patients. After the end of the still blinded second cycle, nine patients voiced their preference for guarana and 17 for placebo (p = 0.059). Cconclusions: In this pilot study, guarana was not effective to prevent chemotherapy-related fatigue and/or depressive symptoms.
first_indexed 2024-12-17T04:48:57Z
format Article
id doaj.art-fb2b97a701aa461f8b1d8716d8e5ad68
institution Directory Open Access Journal
issn 1679-4508
language English
last_indexed 2024-12-17T04:48:57Z
publishDate 2008-09-01
publisher Instituto Israelita de Ensino e Pesquisa Albert Einstein
record_format Article
series Einstein (São Paulo)
spelling doaj.art-fb2b97a701aa461f8b1d8716d8e5ad682022-12-21T22:02:58ZengInstituto Israelita de Ensino e Pesquisa Albert EinsteinEinstein (São Paulo)1679-45082008-09-0162195199Guaraná (Paullinia cupana) for chemotherapy-related fatigueAuro Del GiglioRachel RiechelmannThaís Zampa de Campos TrindadeVinicius de OliveiraLucas Scatigno SaadFlávia Delgado MartinsÂngelo Bezerra de Souza FêdeDamila Cristina TrufelliVanessa da Costa MirandaObjective: To evaluate the effect of guarana in patients with solid tumors starting on chemotherapy, insofar as chemotherapy-induced fatigue and depressive symptoms are concerned. Methods: This is a double-blind, cross-over trial in which chemotherapy naive patients were randomized to take either guarana 75 mg or placebo tablets during the first cycle of chemotherapy and then switched to the alternative for the second cycle. We evaluated fatigue and depressive symptoms using Portuguese-validated instruments: Chalder Fatigue Scale, Brief Fatigue Inventory, and Beck Depression Inventory. Rresults: From January to June 2007, 38 patients were recruited and 12 dropped out before outcome assessments. We did not observe any statistically significant differences between or within groups in fatigue or depression scores among the 26 evaluable patients. After the end of the still blinded second cycle, nine patients voiced their preference for guarana and 17 for placebo (p = 0.059). Cconclusions: In this pilot study, guarana was not effective to prevent chemotherapy-related fatigue and/or depressive symptoms.http://www.einstein.br/revista/arquivos/PDF/846-Einsteinv6n2p195-9.pdfPaulliniaFatigue/etiologyDepression/etiologyNeoplasms/complicationsNeoplasms/psychologyNeoplasms/drug therapyDrug therapy
spellingShingle Auro Del Giglio
Rachel Riechelmann
Thaís Zampa de Campos Trindade
Vinicius de Oliveira
Lucas Scatigno Saad
Flávia Delgado Martins
Ângelo Bezerra de Souza Fêde
Damila Cristina Trufelli
Vanessa da Costa Miranda
Guaraná (Paullinia cupana) for chemotherapy-related fatigue
Einstein (São Paulo)
Paullinia
Fatigue/etiology
Depression/etiology
Neoplasms/complications
Neoplasms/psychology
Neoplasms/drug therapy
Drug therapy
title Guaraná (Paullinia cupana) for chemotherapy-related fatigue
title_full Guaraná (Paullinia cupana) for chemotherapy-related fatigue
title_fullStr Guaraná (Paullinia cupana) for chemotherapy-related fatigue
title_full_unstemmed Guaraná (Paullinia cupana) for chemotherapy-related fatigue
title_short Guaraná (Paullinia cupana) for chemotherapy-related fatigue
title_sort guarana paullinia cupana for chemotherapy related fatigue
topic Paullinia
Fatigue/etiology
Depression/etiology
Neoplasms/complications
Neoplasms/psychology
Neoplasms/drug therapy
Drug therapy
url http://www.einstein.br/revista/arquivos/PDF/846-Einsteinv6n2p195-9.pdf
work_keys_str_mv AT aurodelgiglio guaranapaulliniacupanaforchemotherapyrelatedfatigue
AT rachelriechelmann guaranapaulliniacupanaforchemotherapyrelatedfatigue
AT thaiszampadecampostrindade guaranapaulliniacupanaforchemotherapyrelatedfatigue
AT viniciusdeoliveira guaranapaulliniacupanaforchemotherapyrelatedfatigue
AT lucasscatignosaad guaranapaulliniacupanaforchemotherapyrelatedfatigue
AT flaviadelgadomartins guaranapaulliniacupanaforchemotherapyrelatedfatigue
AT angelobezerradesouzafede guaranapaulliniacupanaforchemotherapyrelatedfatigue
AT damilacristinatrufelli guaranapaulliniacupanaforchemotherapyrelatedfatigue
AT vanessadacostamiranda guaranapaulliniacupanaforchemotherapyrelatedfatigue